9 reports

  • Number of Products under Development by Indication, H1 2016
  • Products under Investigation by Universities/Institutes, H1 2016

Salk Institute for Biological Studies is investigating CNB-## for the treatment of ischemic stroke, Alzheimer' s disease, Huntington' s disease, Parkinson' s disease, Lung inflammation (asthma) and traumatic brain injury (TBI).

  • Health Services
  • Malaria
  • World
  • Product Initiative
  • Sumitomo Dainippon Pharma Co., Ltd.
  • MALARIA - PIPELINE BY LONDONPHARMA LTD, H1 2017
  • MALARIA - PIPELINE BY MARINOMED BIOTECHNOLOGIE GMBH, H1 2017

Marinomed also develops MAM-##. ##, an allergy compound that provides an alternative to skin allergy, allergic asthma and allergic contact dermatitis.

  • Malaria
  • Research And Development
  • United States
  • World
  • Product Initiative
  • GENVEC INC
  • MALARIA - PIPELINE BY MARINOMED BIOTECHNOLOGIE GMBH, H2 2017

Marinomed also develops MAM-##. ##, an allergy compound that provides an alternative to skin allergy, allergic asthma and allergic contact dermatitis.

  • Malaria
  • Research And Development
  • United States
  • Product Initiative
  • Sanaria Inc.
  • GENVEC ENTERS INTO RESEARCH AGREEMENT WITH LMIV

The institute' s research areas include infectious diseases such as tuberculosis and influenza, HIV/ AIDS, biodefense; and immune-mediated diseases including asthma and allergy.

  • Healthcare
  • Malaria
  • Pharmaceutical
  • United States
  • GenVec, Inc.

Its ketas product is a phosphodiesterase inhibitor agent for ameliorating bronchial asthma and cerebro-vascular disorders.

  • Cancer
  • Malaria
  • Japan
  • United States
  • Eisai Co., Ltd.
  • DESIGNMEDIX ENTERS INTO AGREEMENT WITH THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

The institute' s research areas include infectious diseases such as tuberculosis and influenza, HIV/ AIDS, biodefense; and immune-mediated diseases including asthma and allergy.

  • Malaria
  • United States
  • Company
  • Deals & Alliance
  • DesignMedix

It was also under development for asthma.

  • Cancer
  • Malaria
  • Therapy
  • United States
  • AstraZeneca PLC

KM-## was tested against standard treatment for asthma and Osteoarthritis.

  • Malaria
  • R&D
  • Research And Development
  • United States
  • Cellceutix Corporation
  • Biomarker
  • Hospital
  • Malaria
  • Sensor
  • Exploit Technologies Pte Ltd